Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 04, 2022

BUY
$242.49 - $301.46 $58,925 - $73,254
243 Added 0.88%
27,758 $6.82 Million
Q2 2022

Aug 10, 2022

BUY
$224.73 - $338.64 $33,484 - $50,457
149 Added 0.54%
27,515 $6.81 Million
Q1 2022

Apr 27, 2022

BUY
$277.25 - $366.29 $22,457 - $29,669
81 Added 0.3%
27,366 $9.07 Million
Q4 2021

Jan 31, 2022

SELL
$300.63 - $371.35 $174,064 - $215,011
-579 Reduced 2.08%
27,285 $9.8 Million
Q3 2021

Oct 20, 2021

SELL
$310.19 - $376.2 $309,879 - $375,823
-999 Reduced 3.46%
27,864 $9.07 Million
Q2 2021

Jul 20, 2021

SELL
$262.71 - $351.17 $392,226 - $524,296
-1,493 Reduced 4.92%
28,863 $9.01 Million
Q1 2021

Apr 22, 2021

SELL
$285.92 - $355.13 $689,353 - $856,218
-2,411 Reduced 7.36%
30,356 $9.68 Million
Q4 2020

Feb 12, 2021

SELL
$251.88 - $324.2 $159,943 - $205,867
-635 Reduced 1.9%
32,767 $10.6 Million
Q3 2020

Nov 06, 2020

SELL
$255.22 - $317.0 $710,022 - $881,894
-2,782 Reduced 7.69%
33,402 $9.26 Million
Q2 2020

Aug 14, 2020

SELL
$141.4 - $257.09 $180,426 - $328,046
-1,276 Reduced 3.41%
36,184 $8.74 Million
Q1 2020

May 13, 2020

SELL
$130.51 - $196.01 $35,498 - $53,314
-272 Reduced 0.72%
37,460 $5.44 Million
Q4 2019

Feb 12, 2020

BUY
$159.31 - $223.54 $121,234 - $170,113
761 Added 2.06%
37,732 $6.44 Million
Q3 2019

Nov 20, 2019

SELL
$175.89 - $279.23 $128,223 - $203,558
-729 Reduced 1.93%
36,971 $6.58 Million
Q2 2019

Aug 14, 2019

BUY
$250.96 - $284.94 $18,069 - $20,515
72 Added 0.19%
37,700 $9.82 Million
Q1 2019

May 13, 2019

BUY
$276.39 - $362.25 $148,697 - $194,890
538 Added 1.45%
37,628 $10.4 Million
Q4 2018

Feb 14, 2019

BUY
$281.08 - $444.25 $62,399 - $98,623
222 Added 0.6%
37,090 $12.1 Million
Q3 2018

Oct 23, 2018

BUY
$354.53 - $449.75 $459,470 - $582,876
1,296 Added 3.64%
36,868 $16.6 Million
Q2 2018

Aug 02, 2018

BUY
$278.07 - $446.21 $9.89 Million - $15.9 Million
35,572 New
35,572 $14.6 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Chevy Chase Trust Holdings, Inc. Portfolio

Follow Chevy Chase Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chevy Chase Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chevy Chase Trust Holdings, Inc. with notifications on news.